Opinion
Civil No. 08-cv-61-JL, Opinion No. 2009 DNH 190.
December 11, 2009
OPINION AND ORDER
This case concerns whether a prison provided adequate medical care to an inmate in the early stages of hepatitis C. Plaintiff Todd Horstkotte, formerly an inmate at the New Hampshire State Prison, has sued various prison officials and staff members alleging that they failed to provide adequate care for his disease. He asserts an Eighth Amendment civil rights claim under 42 U.S.C. § 1983, a discrimination claim under the Americans with Disabilities Act ("ADA"), 42 U.S.C. § 12132, and state-law claims for negligence, medical malpractice, and intentional infliction of emotional distress. This court has jurisdiction under 28 U.S.C. §§ 1331 (federal question) and 1367 (supplemental jurisdiction).
Horstkotte also asserted a number of other claims that this court previously dismissed on the merits, as recommended by Judge Muirhead without objection from Horstkotte. Document nos. 4 (Muirhead, M.J.) and 24.
Earlier in the case, this court denied Horstkotte's request for preliminary injunctive relief, finding that he was unlikely to succeed on the merits. The defendants have now moved for summary judgment, see Fed.R.Civ.P. 56, making substantially the same arguments that they made at the preliminary stage. Horstkotte, who is proceeding pro se, has not objected. After reviewing the summary judgment record, this court grants the motion. While Horstkotte may have preferred a more aggressive approach to his hepatitis C infection, the defendants have shown that they provided adequate medical care based on legitimate medical considerations.
Document nos. 57 (Muirhead, M.J.) and 63.
I. Applicable legal standard
Summary judgment is appropriate where "the pleadings, the discovery and disclosure materials on file, and any affidavits show that there is no genuine issue as to any material fact and that the movant is entitled to a judgment as a matter of law." Fed.R.Civ.P. 56(c). An issue is "genuine" if it may reasonably be resolved in either party's favor at trial, and "material" if it has the capacity to sway the outcome under applicable law.Vineberg v. Bissonnette, 548 F.3d 50, 56 (1st Cir. 2008) (quotations omitted). In making this determination, the "court must scrutinize the record in the light most flattering to the party opposing the motion, indulging all reasonable inferences in that party's favor." Mulvihill v. Top-Flite Golf Co., 335 F.3d 15, 19 (1st Cir. 2003).
Where, as here, the non-moving party files no response to the summary judgment motion, "[a]ll properly supported material facts in the moving party's factual statement shall be deemed admitted," since they were not "properly opposed." L.R. 7.2(b)(2); see also De Jesus v. LTT Card Svcs., Inc., 474 F.3d 16, 20 (1st Cir. 2007). Summary judgment does not, however, "automatically follow." Stonkus v. City of Brockton Sch. Dep't, 322 F.3d 97, 102 (1st Cir. 2003). The court still must evaluate whether the moving party's submission meets the summary judgment standard. See Fed.R.Civ.P. 56(e) ("If the adverse party does not . . . respond, summary judgment, if appropriate, shall be entered against the adverse party.") (emphasis added). Consistent with this approach, the following background summary is based on the defendants' factual statement, which is supported by affidavits, medical records, and testimony from the preliminary injunction hearing.
II. Background
Horstkotte arrived at the New Hampshire State Prison in June 2007 to begin serving a prison sentence with a three-year maximum. As part of the routine intake process, he underwent a medical exam and blood tests. The tests revealed an elevated liver enzyme level, most commonly associated with the hepatitis C virus. Further testing confirmed the presence of the virus. Because Horstkotte had tested negative for the virus in June 2005 and had a normal liver enzyme level in November 2005, the prison's chief medical officer — defendant Dr. Celia Englander — concluded that he must have contracted the disease within the preceding year-and-a-half. Horstkotte agrees with that conclusion.
Dr. Englander is a board-certified physician who has been practicing medicine for 25 years and has significant experience with hepatitis C patients.
After the diagnosis, Dr. Englander evaluated whether Horstkotte was an appropriate candidate for hepatitis C treatment. The treatment involves a combination of two drugs (ribavirin and pegylated interferon) that can have serious side effects. Under prison protocol, an inmate is eligible for treatment only if his minimum sentence is long enough to complete the entire treatment process, which takes at least two-and-a-half years (including one year of assessment, one year of drug therapy, and six months of follow-up care). This requirement is based on a medical concern that incomplete or interrupted treatment could lead to drug resistance or other adverse effects. Since Horstkotte's minimum parole date was only six months away (in January 2008), Dr. Englander deemed him ineligible for treatment under the protocol.
The prison allows its medical staff to depart from the protocol where medically necessary to treat inmates at advanced stages of hepatitis C. But Dr. Englander concluded that no departure was medically necessary in Horstkotte's case because he was at a very early stage of the disease and not suffering any symptoms. Hepatitis C is a slow-moving disease that can take decades to progress to the point where it creates serious health problems requiring treatment. In some cases, the disease never reaches that point because the body's natural immune response suppresses or even eliminates it. Dr. Englander relied on materials from the National Institutes of Health and other sources indicating that drug combination therapy generally is not recommended in the early stages of the disease, given the potential side effects and the possibility of natural suppression. She saw no significant threat to Horstkotte's health from waiting to see how his immune system responded.
Horstkotte complained of various symptoms (e.g., leg and elbow pain, abdomen pain, light stool, and dark urine), but Dr. Englander has ruled out any connection between these complaints and hepatitis C, which generally is asymptomatic in its early stages.
Horstkotte, who wanted to take a more aggressive approach, requested a liver biopsy. Dr. Englander considered the biopsy medically unnecessary because its primary purpose is to determine the stage of the disease, which she already knew. Nevertheless, in lieu of a biopsy, she allowed Horstkotte to undergo a FibroSURE test in October 2007 to measure fibrosis in his liver. The test provides information similar to a liver biopsy, but is less invasive and less dangerous for the patient. The test measured Horstkotte's fibrosis level near the bottom of stage one (out of five stages, where stage five is the worst). Dr. Englander concluded that, because the test tends to be overly sensitive, Horstkotte's fibrosis level might even be below stage one. Given the slow progression of the disease, she saw no realistic chance that Horstkotte's fibrosis level would increase to a stage requiring treatment before the end of his prison sentence.
Horstkotte also received vaccinations against hepatitis A and B, for which he tested negative.
Dr. Englander met with Horstkotte in December 2007 and explained to him the FibroSURE test results and her medical opinion. She also gave him advice about living with hepatitis C. For the rest of Horstkotte's sentence, the prison's medical staff continued to monitor the status of his disease. In April 2008, further blood testing revealed that Horstkotte's liver enzyme level had dropped considerably since his arrival in prison. Six months later, in October 2008, Horstkotte was released on parole.
Horstkotte was initially denied parole in January 2008. In his complaint, filed the following month, he alleged that the prison violated his due process rights by delaying that parole hearing for two weeks. As reformulated by Judge Muirhead, however, the complaint no longer included that claim. Documents no. 4 and 24. Horstkotte did not object to that ruling and thus waived his claim. In any event, Judge Muirhead found — and this court agreed — that the two-week delay "is not a deprivation of due process." Document nos. 57 (Muirhead, M.J.) and 63.
III. Analysis
A. Eighth Amendment claim
Eighth Amendment Eighth AmendmentSeeU.S. Const. amend. VIIIFeeney v. Corr. Med. Servs., Inc.464 F.3d 158161Estelle v. Gamble429 U.S. 97105-06Farmer v. Brennan511 U.S. 825834DesRosiers v. Moran949 F.2d 1518See Feeney464 F.3d at 162Id. Torraco v. Maloney923 F.2d 231234
As to the objective component, the defendants have shown that Horstkotte did not have a serious medical need for the more aggressive treatment he wanted. Dr. Englander, an experienced physician, concluded that Horstkotte was at a very early stage of hepatitis C, free of any symptoms, and unlikely to progress to a more advanced stage of the disease for many years, if at all. Horstkotte faced no significant health risk, in her view, from waiting to see how his immune system responded to the disease. In fact, she concluded that it was the aggressive treatment, not the wait-and-see approach, that posed an unnecessary risk of harm at that stage, given its potential side effects. These conclusions were all based on legitimate medical considerations, and Horstkotte has not presented any evidence that puts them in genuine dispute.
As to the subjective component, the defendants have shown that they did not act with deliberate indifference. Dr. Englander provided a good-faith explanation for all of her treatment decisions. Moreover, in order to calm Horstkotte's fears, she even allowed him to undergo extra testing that she considered medically unnecessary — a far cry from wantonly disregarding his rights. The testing confirmed her conclusion that Horstkotte's disease was at an early stage and did not require more aggressive treatment. Prison medical staff continued to monitor his condition for the rest of his time in prison and saw significant improvement in his liver enzyme levels. This is not a case "where the attention received is `so clearly inadequate as to amount to a refusal to provide essential care.'" Feeney, 464 F.3d at 163 (quoting Torraco, 923 F.2d at 234). It is a case where, despite having received adequate attention and essential care, Horstkotte disagreed with his doctor's approach. "[W]hen a plaintiff's allegations simply reflect a disagreement on the appropriate course of treatment, such a dispute with an exercise of professional judgment . . . falls short of alleging a constitutional violation." Id. at 162 (quotation omitted).
Our court of appeals recently affirmed the dismissal on summary judgment of a nearly identical Eighth Amendment claim. See Castello v. Martin, 197 Fed. Appx. 14 (1st Cir. 2006) (unpublished). In that case, the inmate also suffered from the early stages of hepatitis C, and the prison also declined to authorize drug combination therapy, opting instead to monitor his condition with blood tests and a liver biopsy. Id. at 15. The court of appeals saw no evidence of deliberate indifference:
While it is clear that [the inmate] strongly disagrees with the medical care he is receiving, it is also clear that [the medical staff] is providing decent, timely health care . . . at a level reasonably commensurate with modern medical science and of a quality acceptable within prudent professional standards. . . . [The evidence] shows that modern medical science has reached a consensus that treatment generally is appropriate for patients suffering more severe cases of [hepatitis C], where a liver biopsy shows moderate inflammation and necrosis and portal or bridging fibrosis. None of these conditions were detected in [the inmate's] liver biopsy. On this record, [the inmate] failed to show that he has suffered an objectively serious deprivation, or that [defendants] have subjectively acted in wanton disregard of his rights. See also Bender v. Regier, 385 F.3d 1133, 1135 (8th Cir. 2004) ("Treatment for [hepatitis C] patients with mild liver problems may be safely deferred.").Id. (quotations omitted).
This case has only two minor differences from Castello, neither of which is constitutionally significant. The first is that Horstkotte underwent a FibroSURE test, rather than a more invasive biopsy, to check his liver for fibrosis. Dr. Englander testified that both tests provide similar information and that she opted for the safer one. Neither test was medically necessary in her opinion, since Horstkotte's disease was already known to be at a very early stage, but she authorized a FibroSURE test anyway because Horstkotte wanted more information. This decision reflected care for, not indifference to, Horstkotte's medical needs. Cf. Hollis v. Dir. of Corr., 560 F. Supp. 2d 920 (C.D. Cal. 2008) (rejecting Eighth Amendment claim where prison denied liver biopsy to inmate in early stages of hepatitis C, even without FibroSURE testing); Jordan v. Delaware, 433 F. Supp. 2d 433 (D. Del. 2006) (same). Moreover, like the liver biopsy inCastello, Horstkotte's FibroSURE test confirmed that he did not have an advanced case of hepatitis C.
The other difference between this case and Castello is that here, the prison applied a specific protocol limiting drug combination therapy to inmates whose minimum sentence is long enough to complete the entire treatment process. The defendants have shown that this requirement is based on a legitimate medical concern that interrupted or incomplete treatment could lead to drug resistance. See, e.g., Troutt v. Corr. Healthcare Mgmt., 248 Fed. Appx. 910, 914 (10th Cir. 2007) (unpublished) (finding no Eighth Amendment violation where prison denied treatment for similar timing reasons). While blind adherence to such a protocol in the face of serious medical needs might raise a triable Eighth Amendment issue, see McKenna v. Wright, 386 F.3d 432 (2d Cir. 2004), that is not what happened here. Dr. Englander testified that she could have departed from that protocol if medically necessary and that she declined to do so because Horstkotte was at an early stage of the disease and was not facing a significant risk of harm. As in Castello, Horstkotte's Eighth Amendment claim for failure to provide adequate medical care must be rejected.See Hines v. Anderson, 547 F.3d 915, 921 (8th Cir. 2008) (finding no Eighth Amendment violation where "[t]here is no evidence that the use of [prison] guidelines is resulting in harm or that the [prison] is deliberately disregarding Hepatitis C diagnoses").
As a separate theory, Horstkotte claims that the defendants violated his Eighth Amendment rights by failing to provide an adequate diet to meet his medical needs. This claim must be dismissed because Horstkotte failed to exhaust his administrative remedies as required by the Prison Litigation Reform Act ("PLRA"), 42 U.S.C. § 1997e(a). He filed an inmate request slip complaining about the prison diet, but never pursued his complaint through the rest of the prison's three-level grievance process, as set forth in Procedure and Policy Directive ("PPD") 1.16. See Ellison v. N.H. Dep't of Corr., 2009 DNH 017, 7-9 (describing each level of the grievance process).
Even if Horstkotte had properly exhausted this claim, however, the summary judgment record establishes that it has no merit. Dr. Englander testified that Horstkotte has no special dietary requirements as a result of his disease and that the prison diet posed no health risks to him. The prison's food service supervisor confirmed that the diet is healthy and provided sample menus highlighting the fruit and vegetable content. Horstkotte has not filed an objection refuting these assertions, which means that they must be treated as admitted. See Part I, supra. They suffice to defeat Horstkotte's Eighth Amendment challenge to the prison diet.
B. ADA claim
Horstkotte also claims that the defendants violated the ADA by denying him the benefit of adequate medical care because he has hepatitis C. The ADA provides in relevant part:
[N]o qualified individual with a disability shall, by reason of such disability, be excluded from participation in or be denied the benefits of the services, programs, or activities of a public entity, or be subjected to discrimination by any such entity.42 U.S.C. § 12132. To prevail on this claim, Horstkotte must show that (1) he is a qualified individual with a disability; (2) that he was either excluded from or denied the benefits of the prison's medical services; and (3) that such exclusion or denial was because of his disability. Toledo v. Sanchez, 454 F.3d 24, 31 (1st Cir. 2006).
The defendants have shown that Horstkotte had no disability while in prison and thus cannot satisfy the first element of his ADA claim. To establish a disability, Horstkotte must prove that he suffers from a physical or mental impairment that imposes a substantial limitation on a major life activity. Rolland v. Potter, 492 F.3d 45, 48 (1st Cir. 2007). This determination is made on a "case-by-case basis." Id. In this case, Dr. Englander testified that Horstkotte was symptom-free and that his disease, still at a very early stage, posed no significant health threat. While hepatitis C might qualify as a disability at a more advanced stage, "numerous courts have held that [hepatitis C] alone, without a demonstration of how it has limited a major life activity, is not enough to qualify as a disability." Amos v. Corr. Med. Svcs., Inc., No. 06-cv-1892, 2009 WL 1884142, at *6 (D.N.J. June 30, 2009) (citing Furnish v. SVI Sys., Inc., 270 F.3d 445, 449 (7th Cir. 2001), and Sussle v. Sirina Prot. Sys. Corp., 269 F. Supp. 2d 285 (S.D.N.Y. 2003)); see also Wilder v. S.C. Dep't of Corr., No. 3:08-2486-MBS, 2009 WL 2948514 (D.S.C. Sept. 1, 2009) (ruling, where inmate's hepatitis C infection was asymptomatic, that it was not a disability under the ADA).
Moreover, even if his hepatitis C infection qualified as a disability under the ADA, Horstkotte still would not be able to prove the third element: that the defendants denied him medical services because of that disability. His claim is really that the defendants refused to treat him for his disability. Our court of appeals has made clear that the "ADA does not create a remedy for medical malpractice," unless the "medical unreasonableness [is] framed within some larger theory of disability discrimination." Kiman v. N.H. Dep't of Corr., 451 F.3d 274, 284 (1st Cir. 2006) (quoting Bryant v. Madigan, 84 F.3d 246, 249 (7th Cir. 1996), and Lesley v. Chie, 250 F.3d 47, 55 (1st Cir. 2001)). Horstkotte has not framed his ADA claim within any larger theory of discrimination; it is just a medical malpractice claim framed within ADA terminology. Courts have consistently rejected such claims in cases involving inmate complaints about hepatitis C treatment. See, e.g., Wilder, 2009 WL 2948514, at *4 (citing Iseley v. Beard, 200 Fed. Appx. 137, 142 (3d Cir. 2006)); Lopez v. Corr. Med. Svcs., No. 04-2155, 2009 WL 1883915, at *11 (D.N.J. June 30, 2009); Jordan, 433 F. Supp. 2d at 442-43. This court, too, concludes that Horstkotte's ADA claim must be denied.
C. State-law tort claims
Finally, Horstkotte claims that the defendants committed three torts — negligence, medical malpractice, and intentional infliction of emotional distress — under New Hampshire state law by failing to provide proper treatment for his hepatitis C infection. As the defendants note, Horstkotte cannot prevail on his negligence and medical malpractice claims without expert testimony. See, e.g., Smith v. HCA Health Svcs. of N.H., Inc., 159 N.H. 158, 160-61 (2009) (applying N.H. Rev. Stat. § 507-E:2, which requires the plaintiff to present expert testimony "[i]n any action for medical injury"); Est. of Joshua T. v. New Hampshire, 150 N.H. 405, 408 (2003) (requiring expert testimony "whenever the matter to be determined is so distinctly related to some science, profession, business or occupation as to be beyond the ken of the average layman"). Horstkotte's expert disclosure deadline passed long ago. He has not designated any experts, requested a deadline extension, or given this court any reason to believe that he intends to present expert testimony at trial. "While courts have historically loosened the reins for pro se parties, the right of self-representation is not a license not to comply with relevant rules of procedural and substantive law."Eagle Eye Fishing Corp. v. U.S. Dep't of Commerce, 20 F.3d 503, 506 (1st Cir. 1994) (quotations omitted). Since Horstkotte lacks the expert testimony needed to create a trialworthy issue, this court grants summary judgment on his negligence and medical malpractice claims. See, e.g., Rojas-Ithier v. Sociedad Espanola de Auxilio Mutuo y Beneficiencia, 394 F.3d 40, 43-44 (1st Cir. 2005) (affirming summary judgment on medical malpractice claim where non-moving party presented no expert testimony).
In most cases, the dismissal of all federal claims before trial "will point toward declining to exercise [supplemental] jurisdiction over the remaining state-law claims."Carnegie-Mellon Univ. v. Cohill, 484 U.S. 343, 350 n. 7 (1988). But there is no "mandatory rule" requiring dismissal; courts must "consider and weigh in each case, and at every stage of the litigation, the values of judicial economy, convenience, fairness, and comity in order to decide whether to exercise jurisdiction." Id. In this case, the close proximity to trial and the heavy overlap between Horstkotte's federal and state-law claims both point in favor of exercising jurisdiction. See, e.g.,Nowak v. Ironworkers Local 6 Pension Fund, 81 F.3d 1182, 1192 (2d Cir. 1996). This court therefore resolves his state-law claims as well.
Document no. 66 (setting a deadline of February 5, 2009).
Whether Horstkotte also needs expert testimony to support his intentional infliction of emotional distress claim is an open question under New Hampshire law. See Saalfrank v. Town of Alton, 2009 DNH 162, 17 (discussing the case law). This court need not answer it now, though, because Horstkotte's claim clearly falls short of the "very high" standard for relief under New Hampshire law. Moss v. Camp Pemigewassett, Inc., 312 F.3d 503, 511 (1st Cir. 2002). To prevail on such a claim, Horstkotte must show that the defendants engaged in "extreme and outrageous conduct" that "intentionally or recklessly cause[d] severe emotional distress."Mikell v. Sch. Admin. Unit No. 33, 158 N.H. 723, 728 (2009). The conduct must go "beyond all possible bounds of decency." Id. As explained above in the Eighth Amendment analysis, the defendants have shown that they acted in good faith and made treatment decisions based on legitimate medical considerations. Under this standard, on this record, the court cannot conclude that their conduct even approaches an extreme or outrageous level. This court therefore grants summary judgment on Horstkotte's emotional distress claim as well.
IV. Conclusion
For the foregoing reasons, the defendants' motion for summary judgment is GRANTED. The clerk shall enter judgment accordingly and close the case.
Document no. 72.